Your browser doesn't support javascript.
loading
ACR Appropriateness Criteria® Palpable Breast Masses.
Moy, Linda; Heller, Samantha L; Bailey, Lisa; D'Orsi, Carl; DiFlorio, Roberta M; Green, Edward D; Holbrook, Anna I; Lee, Su-Ju; Lourenco, Ana P; Mainiero, Martha B; Sepulveda, Karla A; Slanetz, Priscilla J; Trikha, Sunita; Yepes, Monica M; Newell, Mary S.
Affiliation
  • Moy L; Principal Author and Panel Vice-Chair, NYU Clinical Cancer Center, New York, New York. Electronic address: linda.moy@nyumc.org.
  • Heller SL; Research Author, New York University School of Medicine, New York, New York.
  • Bailey L; Bay Area Breast Surgeons, Emeryville, California; American College of Surgeons.
  • D'Orsi C; Emory University Hospital, Atlanta, Georgia.
  • DiFlorio RM; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Green ED; The University of Mississippi Medical Center, Jackson, Mississippi.
  • Holbrook AI; Emory University Hospital, Atlanta, Georgia.
  • Lee SJ; University of Cincinnati, Cincinnati, Ohio.
  • Lourenco AP; Rhode Island Hospital, Providence, Rhode Island.
  • Mainiero MB; Rhode Island Hospital, Providence, Rhode Island.
  • Sepulveda KA; Baylor College of Medicine, Houston, Texas.
  • Slanetz PJ; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Trikha S; Northwell Health, Syosset, New York.
  • Yepes MM; University of Miami, Miami, Florida.
  • Newell MS; Panel Chair, Emory University Hospital, Atlanta, Georgia.
J Am Coll Radiol ; 14(5S): S203-S224, 2017 May.
Article in En | MEDLINE | ID: mdl-28473077
ABSTRACT
Breast cancer is the most common female malignancy and the second leading cause of female cancer death in the United States. Although the majority of palpable breast lumps are benign, a new palpable breast mass is a common presenting sign of breast cancer. Any woman presenting with a palpable lesion should have a thorough clinical breast examination, but because many breast masses may not exhibit distinctive physical findings, imaging evaluation is necessary in almost all cases to characterize the palpable lesion. Recommended imaging options in the context of a palpable mass include diagnostic mammography and targeted-breast ultrasound and are dependent on patient age and degree of radiologic suspicion as detailed in the document Variants. There is little role for advanced technologies such as MRI, positron emission mammography, or molecular breast imaging in the evaluation of a palpable mass. When a suspicious finding is identified, biopsy is indicated. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Guideline / Prognostic_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: J Am Coll Radiol Journal subject: RADIOLOGIA Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Guideline / Prognostic_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: J Am Coll Radiol Journal subject: RADIOLOGIA Year: 2017 Document type: Article